Back to search
Low-grade NMIBC
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Low-grade NMIBC trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Low-grade NMIBC trials you may qualify forPhase 2 Study of TYRA-300 in FGFR3 Altered Low Grade, Intermediate Risk NMIBC
The goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose…
This Phase 3, single-arm, multicenter study will evaluate the efficacy and safety of UGN-103, a novel formulation of UGN-102, instilled in the urinary bladder o…
This is a single-arm, phase 1/2a study of formulated paclitaxel in subjects with low-grade, noninvasive papillary carcinoma (stage Ta) of the bladder. Part 1 o…